Sinovac Biotech Ltd (OTCBB:SNVBF) Wer kennt diese Firma - 500 Beiträge pro Seite
eröffnet am 25.12.03 19:31:41 von
neuester Beitrag 25.12.03 22:58:55 von
neuester Beitrag 25.12.03 22:58:55 von
Beiträge: 6
ID: 806.632
ID: 806.632
Aufrufe heute: 0
Gesamt: 387
Gesamt: 387
Aktive User: 0
Top-Diskussionen
| Titel | letzter Beitrag | Aufrufe |
|---|---|---|
| vor 1 Stunde | 421 | |
| vor 39 Minuten | 135 | |
| gestern 19:02 | 114 | |
| gestern 21:36 | 79 | |
| gestern 23:08 | 74 | |
| vor 17 Minuten | 73 | |
| gestern 23:36 | 68 | |
| vor 15 Minuten | 60 |
Meistdiskutierte Wertpapiere
| Platz | vorher | Wertpapier | Kurs | Perf. % | Anzahl | ||
|---|---|---|---|---|---|---|---|
| 1. | 1. | 18.503,00 | +0,34 | 294 | |||
| 2. | 2. | 174,10 | -2,09 | 109 | |||
| 3. | 3. | 10,230 | +447,06 | 107 | |||
| 4. | 4. | 0,1935 | +2,38 | 77 | |||
| 5. | 7. | 0,9600 | -14,29 | 70 | |||
| 6. | 6. | 1,1100 | -3,48 | 60 | |||
| 7. | 5. | 4,1725 | -5,17 | 57 | |||
| 8. | 8. | 5,9840 | -1,55 | 48 |
Feedback
Hallo Freunde
Wer hat schon Aktien dieser Firma?????
JS200
Wer hat schon Aktien dieser Firma?????
JS200
Sinovac Biotech Listed in Standard and Poor`s Corporation
Monday , December 01, 2003 09:05 ET
BEIJING, CHINA, Dec 1, 2003 (CCNMatthews via COMTEX) -- Sinovac Biotech Ltd. ("Sinovac") (NASD OTC-BB: SNVBF) is pleased to confirm that the Editorial Board of Standard and Poor`s ("S & P") has approved Sinovac for a complete corporate listing and description in Standard and Poor`s Corporation Records. Additionally, Sinovac will have its corporate description published in Standard and Poor`s Daily News Section. S & P will initiate financial coverage of Sinovac as part of the S & P Market Access Program, including coverage of Sinovac on S & P`s Internet website, www.advisorsight.com as well as S & P Marketscope and the electronic version of S & P Stock Guide database. Additionally, the S & P coverage will appear on the highly trafficked OTC Bulletin Board web site www.otcbb.com.
Standard Corporation Records is a recognized securities manual for the "Blue Sky" Standard Manual Exemption for secondary trading in more than 35 states. Sinovac`s listing in Standard Corporation Records should assist the brokerage and investment communities in making a market for Sinovac Biotech`s stock. It is recommended that brokers check with their compliance officers or legal counsel for applicable "Blue Sky" laws and regulations pertaining to them.
ABOUT SINOVAC BIOTECH LTD.
Sinovac Biotech Ltd. specializes in the research, development, commercialization, and sales of human vaccines for infectious illnesses such as Hepatitis A and Hepatitis B, influenza and "SARS."
For further information please refer to the Company`s 6K filing with the SEC on 26 September 2003 or refer to Sinovac`s website at http://www.sinovac.com/.
THIS NEWS RELEASE MAY INCLUDE FORWARD-LOOKING STATEMENTS WITHIN THE MEANING OF SECTION 27A OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, AND SECTION 21E OF THE UNITED STATES SECURITIES AND EXCHANGE ACT OF 1934, AS AMENDED, WITH RESPECT TO ACHIEVING CORPORATE OBJECTIVES, DEVELOPING ADDITIONAL PROJECT INTERESTS, SINOVAC`S ANALYSIS OF OPPORTUNITIES IN THE ACQUISITION AND DEVELOPMENT OF VARIOUS PROJECT INTERESTS AND CERTAIN OTHER MATTERS. THESE STATEMENTS ARE MADE UNDER THE "SAFE HARBOR" PROVISIONS OF THE UNITED STATES PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 AND INVOLVE RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE IN THE FORWARD-LOOKING STATEMENTS CONTAINED HEREIN. THIS NEWS RELEASE SHALL NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY NOR SHALL THERE BE ANY SALE OF THESE SECURITIES IN ANY JURISDICTION IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL PRIOR TO REGISTRATION OR QUALIFICATION UNDER THE SECURITIES LAWS OF ANY SUCH JURISDICTION.
CONTACT: Sinovac Biotech Ltd.
Graham Taylor
(888) 888-8312
Website: www.sinovac.com
Copyright (C) 2003, CCNMatthews. All rights reserved.
JS200
Monday , December 01, 2003 09:05 ET
BEIJING, CHINA, Dec 1, 2003 (CCNMatthews via COMTEX) -- Sinovac Biotech Ltd. ("Sinovac") (NASD OTC-BB: SNVBF) is pleased to confirm that the Editorial Board of Standard and Poor`s ("S & P") has approved Sinovac for a complete corporate listing and description in Standard and Poor`s Corporation Records. Additionally, Sinovac will have its corporate description published in Standard and Poor`s Daily News Section. S & P will initiate financial coverage of Sinovac as part of the S & P Market Access Program, including coverage of Sinovac on S & P`s Internet website, www.advisorsight.com as well as S & P Marketscope and the electronic version of S & P Stock Guide database. Additionally, the S & P coverage will appear on the highly trafficked OTC Bulletin Board web site www.otcbb.com.
Standard Corporation Records is a recognized securities manual for the "Blue Sky" Standard Manual Exemption for secondary trading in more than 35 states. Sinovac`s listing in Standard Corporation Records should assist the brokerage and investment communities in making a market for Sinovac Biotech`s stock. It is recommended that brokers check with their compliance officers or legal counsel for applicable "Blue Sky" laws and regulations pertaining to them.
ABOUT SINOVAC BIOTECH LTD.
Sinovac Biotech Ltd. specializes in the research, development, commercialization, and sales of human vaccines for infectious illnesses such as Hepatitis A and Hepatitis B, influenza and "SARS."
For further information please refer to the Company`s 6K filing with the SEC on 26 September 2003 or refer to Sinovac`s website at http://www.sinovac.com/.
THIS NEWS RELEASE MAY INCLUDE FORWARD-LOOKING STATEMENTS WITHIN THE MEANING OF SECTION 27A OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, AND SECTION 21E OF THE UNITED STATES SECURITIES AND EXCHANGE ACT OF 1934, AS AMENDED, WITH RESPECT TO ACHIEVING CORPORATE OBJECTIVES, DEVELOPING ADDITIONAL PROJECT INTERESTS, SINOVAC`S ANALYSIS OF OPPORTUNITIES IN THE ACQUISITION AND DEVELOPMENT OF VARIOUS PROJECT INTERESTS AND CERTAIN OTHER MATTERS. THESE STATEMENTS ARE MADE UNDER THE "SAFE HARBOR" PROVISIONS OF THE UNITED STATES PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 AND INVOLVE RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE IN THE FORWARD-LOOKING STATEMENTS CONTAINED HEREIN. THIS NEWS RELEASE SHALL NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY NOR SHALL THERE BE ANY SALE OF THESE SECURITIES IN ANY JURISDICTION IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL PRIOR TO REGISTRATION OR QUALIFICATION UNDER THE SECURITIES LAWS OF ANY SUCH JURISDICTION.
CONTACT: Sinovac Biotech Ltd.
Graham Taylor
(888) 888-8312
Website: www.sinovac.com
Copyright (C) 2003, CCNMatthews. All rights reserved.
JS200
Hallo lieber JS
ich schätze mal das es noch 10 bis 15 % hoch geht.
Die 2,00 wird wohl nicht beim ersten mal ohne News
überwunden werden. Deshalb weiter Beobachten. Denn
der Aufstieg ging zu schnell. Konsoldierung sollte in Kürze eintreten.
mfg jojobada Post ist für Dich da !!
ich schätze mal das es noch 10 bis 15 % hoch geht.
Die 2,00 wird wohl nicht beim ersten mal ohne News
überwunden werden. Deshalb weiter Beobachten. Denn
der Aufstieg ging zu schnell. Konsoldierung sollte in Kürze eintreten.
mfg jojobada Post ist für Dich da !!
@JOJO
Danke für den Chart
Ich gehe auch von einer Konsolidierung aus, aber trotzdem, es könnte sehr schnell hochgehen
JS200
Danke für den Chart
Ich gehe auch von einer Konsolidierung aus, aber trotzdem, es könnte sehr schnell hochgehen
JS200
NET FORCE SYSTEMS
Lokale ID: P8696W104 Symbol: SNVBF Branche: Gütertyp: Land:
15 Minuten verzögerte Kurse
Börse Symbol Währ. Vortag akt.Kurs Diff. % Handelsvol. gehand. St. Kurszeit
OTCBB SNVBF USD 1,71 1,73 + 0,020 + 1,17 19.638 11.370 24. Dez 22:
Hmmmmmmmmmm
JS200
Lokale ID: P8696W104 Symbol: SNVBF Branche: Gütertyp: Land:
15 Minuten verzögerte Kurse
Börse Symbol Währ. Vortag akt.Kurs Diff. % Handelsvol. gehand. St. Kurszeit
OTCBB SNVBF USD 1,71 1,73 + 0,020 + 1,17 19.638 11.370 24. Dez 22:
Hmmmmmmmmmm
JS200
Trading Spotlight
SINOVAC BIOTECH
WKN: Symbol: Branche: Gütertyp: Land:
15 Minuten verzögerte Kurse
Börse Symbol Währ. Vortag akt.Kurs Diff. % Handelsvol. gehand. St. Kurszeit
Berlin EUR 1,37 1,40 + 0,030 + 2,19 0 0 23. Dez 09:08
JS200
WKN: Symbol: Branche: Gütertyp: Land:
15 Minuten verzögerte Kurse
Börse Symbol Währ. Vortag akt.Kurs Diff. % Handelsvol. gehand. St. Kurszeit
Berlin EUR 1,37 1,40 + 0,030 + 2,19 0 0 23. Dez 09:08
JS200
DurchsuchenBeitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Meistdiskutiert
| Wertpapier | Beiträge | |
|---|---|---|
| 294 | ||
| 109 | ||
| 107 | ||
| 77 | ||
| 70 | ||
| 60 | ||
| 57 | ||
| 48 | ||
| 45 | ||
| 44 |
| Wertpapier | Beiträge | |
|---|---|---|
| 33 | ||
| 28 | ||
| 27 | ||
| 27 | ||
| 25 | ||
| 22 | ||
| 21 | ||
| 20 | ||
| 18 | ||
| 18 |
